Verition Fund Management »

Seres Therapeutics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Seres Therapeutics (MCRB) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Seres Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Seres Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Seres Therapeutics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $227k 314k 0.72
2023-09-30 $148k 62k 2.38
2020-09-30 $8.1M 286k 28.32

More positions owned by Verition Fund Management

Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
Amazon (AMZN)
Apple Put Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Netflix (NFLX)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
DTE Energy Company (DTE)
Sempra Energy (SRE)
Truist Financial Corp equities Put Option (TFC)
PPL Corporation Call Option (PPL)
Old National Ban (ONB)
Broadcom Put Option (AVGO)
NiSource (NI)

View all positions for Verition Fund Management

Top funds holding Seres Therapeutics

Flagship Ventures Management
Vanguard Group
BlackRock
BlackRock
Susquehanna International
Geode Capital Management
Charles Schwab Investment Management
Goldman Sachs Group
Schonfeld Strategic Advisors
Vontobel Holding
Lion Point Capital
State Street Corporation
Citadel Advisors
Verition Fund Management
Cantor Fitzgerald, L. P.

View all funds holding Seres Therapeutics